| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 人类营养品(元) | 2,034,190,234.93 | 4,696,571,027.09 | 2,022,422,175.88 |
| 医药商业(元) | - | - | 1,185,066,426.29 |
| 医药制造(元) | - | - | 1,160,289,909.93 |
| 药品(元) | 2,223,472,546.43 | 4,580,145,103.86 | - |
| 其他(元) | 36,754,586.65 | 59,745,253.80 | 23,470,735.85 |
| 营业成本(元) | |||
| 人类营养品(元) | 916,420,805.96 | 2,135,414,920.53 | 1,222,825,218.10 |
| 医药商业(元) | - | - | 1,136,635,473.38 |
| 医药制造(元) | - | - | 449,897,220.74 |
| 药品(元) | 1,632,564,295.05 | 3,181,250,032.88 | - |
| 其他(元) | 22,861,470.63 | 48,814,639.30 | 22,231,726.76 |
| 毛利(元) | |||
| 人类营养品(元) | 1,117,769,428.97 | 2,561,156,106.56 | 799,596,957.78 |
| 医药商业(元) | - | - | 48,430,952.91 |
| 医药制造(元) | - | - | 710,392,689.19 |
| 药品(元) | 590,908,251.38 | 1,398,895,070.98 | - |
| 其他(元) | 13,893,116.02 | 10,930,614.50 | 1,239,009.09 |
| 毛利率(%) | |||
| 人类营养品(%) | 54.95 | 54.53 | 39.54 |
| 医药商业(%) | - | - | 4.09 |
| 医药制造(%) | - | - | 61.23 |
| 药品(%) | 26.58 | 30.54 | - |
| 其他(%) | 37.80 | 18.30 | 5.28 |
| 收入构成(%) | |||
| 人类营养品(%) | 47.37 | 50.30 | 46.06 |
| 医药商业(%) | - | - | 26.99 |
| 医药制造(%) | - | - | 26.42 |
| 药品(%) | 51.78 | 49.06 | - |
| 其他(%) | 0.86 | 0.64 | 0.53 |
| 毛利构成(%) | |||
| 人类营养品(%) | 64.89 | 64.50 | 51.27 |
| 医药商业(%) | - | - | 3.11 |
| 医药制造(%) | - | - | 45.55 |
| 药品(%) | 34.30 | 35.23 | - |
| 其他(%) | 0.81 | 0.28 | 0.08 |